Randal J. Kirk, identified as "Other" in regulatory filings, executed a significant sale of PRECIGEN, INC. (PGEN) shares on March 31, 2026. Kirk sold 2,334,420 shares at a price of $3.30 each, resulting in a total transaction value of approximately $7.70 million.
This transaction adds to a series of sales by Kirk in PRECIGEN, INC. earlier in the week. Filings indicate multiple sales occurring on March 30, 2026, totaling over 2.1 million shares and approximately $6.7 million.
Insider selling activity can be attributed to various personal financial strategies, such as portfolio diversification or tax planning, and does not inherently signal a negative view of the company's future prospects.